tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Myriad Genetics Inc

MYGN
Add to Watchlist
5.920USD
0.0000.00%
Close 11-06 16:00（ET）
566.25MMarket Cap
LossP/E TTM

Myriad Genetics Inc

5.920
0.0000.00%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementRevenueEarningsCompany ValuationRisk Assessment

MYGN Financials

See Myriad Genetics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
566.25M
Dividend TTM
0.00
P/E TTM
-1.37
EPS TTM
-4.31
Revenue
824.50M
Net Profit
-127.30M
ROE
-76.73%
ROA
-47.61%
Myriad Genetics Inc Earnings Date
Latest Release
Nov 4, 2026
EPS / Forecast
-0.46/-0.20
Revenue / Forecast
202.70M/191.33M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-55.87%-0.46
87.25%-0.46
-33288.07%-0.36
81.93%-0.08
-21.06%-0.29
-782.04%-3.57
99.62%0.00
-29.48%-0.47
67.52%-0.24
71.49%-0.41
57.02%-0.29
30.68%-0.36
---0.75
---1.42
---0.67
---0.52
---0.87
----
----
----
Revenue
-1.46%202.70M
-10.51%190.70M
2.30%200.40M
-0.38%209.80M
-3.56%205.70M
0.76%213.10M
-3.12%195.90M
7.12%210.60M
11.15%213.30M
15.26%211.50M
11.59%202.20M
10.57%196.60M
22.70%191.90M
2.34%183.50M
9.88%181.20M
10.57%177.80M
-6.52%156.40M
-5.33%179.30M
-4.74%164.90M
72.53%160.80M
Net Profit
-60.22%-43.90M
86.93%-43.20M
-34000.00%-34.10M
81.41%-7.90M
-23.98%-27.40M
-800.54%-330.50M
99.62%-100.00K
-36.22%-42.50M
63.95%-22.10M
68.39%-36.70M
52.47%-26.00M
26.24%-31.20M
-74.64%-61.30M
-723.40%-116.10M
-166.83%-54.70M
-456.58%-42.30M
-242.68%-35.10M
-200.00%-14.10M
48.10%-20.50M
86.28%-7.60M
Net Margin
-62.59%-21.66%
85.39%-22.65%
-33231.97%-17.02%
81.34%-3.77%
-28.56%-13.32%
-793.78%-155.09%
99.60%-0.05%
-27.16%-20.18%
67.56%-10.36%
72.57%-17.35%
57.40%-12.86%
33.29%-15.87%
---31.94%
---63.27%
---30.19%
---23.79%
---13.92%
----
----
----
Gross Margin
-2.82%67.93%
-6.51%66.60%
0.23%68.66%
-2.35%69.97%
-0.46%69.91%
2.42%71.23%
0.67%68.50%
4.35%71.65%
0.35%70.23%
1.53%69.55%
1.07%68.05%
-1.46%68.67%
--69.98%
--68.50%
--67.33%
--69.69%
--70.42%
----
----
----
Debt to assets ratio
21.12%19.88%
115.41%18.89%
202.96%17.86%
340.33%16.97%
355.05%16.41%
145.27%8.77%
69.13%5.89%
14.76%3.85%
7.65%3.61%
10.55%3.58%
--3.48%
--3.36%
--3.35%
--3.23%
--0.00%
--0.00%
--0.00%
----
----
----
Income Statement
Revenue
-1.46%202.70M
-10.51%190.70M
2.30%200.40M
-0.38%209.80M
-3.56%205.70M
0.76%213.10M
-3.12%195.90M
7.12%210.60M
11.15%213.30M
15.26%211.50M
11.59%202.20M
10.57%196.60M
22.70%191.90M
2.34%183.50M
9.88%181.20M
10.57%177.80M
-6.52%156.40M
-5.33%179.30M
-4.74%164.90M
72.53%160.80M
Operating profit
-71.24%-39.90M
-211.20%-38.90M
12.76%-25.30M
82.66%-3.00M
-30.90%-23.30M
49.80%-12.50M
-3.94%-29.00M
23.79%-17.30M
31.01%-17.80M
31.22%-24.90M
46.55%-27.90M
50.65%-22.70M
42.67%-25.80M
-103.37%-36.20M
-250.34%-52.20M
-367.44%-46.00M
43.40%-45.00M
4.30%-17.80M
67.47%-14.90M
125.18%17.20M
Net Profit
-60.22%-43.90M
86.93%-43.20M
-34000.00%-34.10M
81.41%-7.90M
-23.98%-27.40M
-800.54%-330.50M
99.62%-100.00K
-36.22%-42.50M
63.95%-22.10M
68.39%-36.70M
52.47%-26.00M
26.24%-31.20M
-74.64%-61.30M
-723.40%-116.10M
-166.83%-54.70M
-456.58%-42.30M
-242.68%-35.10M
-200.00%-14.10M
48.10%-20.50M
86.28%-7.60M
Balance Sheet
Current assets
-21.14%271.90M
1.65%289.00M
8.91%312.80M
11.61%332.60M
17.60%344.80M
-2.50%284.30M
-1.07%287.20M
-4.97%298.00M
10.47%293.20M
-0.92%291.60M
10.97%290.30M
14.20%313.60M
-24.67%265.40M
-19.83%294.30M
-38.79%261.60M
-43.36%274.60M
-29.38%352.30M
-31.88%367.10M
29.83%427.40M
46.16%484.80M
Total current liabilities
-7.03%137.60M
-34.62%130.70M
-13.83%130.20M
-18.46%133.80M
-4.08%148.00M
34.25%199.90M
3.42%151.10M
5.26%164.10M
-26.28%154.30M
-32.65%148.90M
1.95%146.10M
13.63%155.90M
62.12%209.30M
84.71%221.10M
-13.67%143.30M
-32.84%137.20M
-36.47%129.10M
-55.83%119.70M
11.41%166.00M
38.98%204.30M
Total assets
-16.33%609.20M
-5.67%638.90M
-33.04%673.70M
-31.24%706.60M
-32.66%728.10M
-37.58%677.30M
-9.40%1.01B
-10.37%1.03B
-5.90%1.08B
-8.60%1.09B
-5.03%1.11B
-4.35%1.15B
-5.19%1.15B
-1.90%1.19B
-6.86%1.17B
-9.24%1.20B
-9.27%1.21B
-11.03%1.21B
-6.10%1.26B
-5.97%1.32B
Total liabilities
-4.25%340.20M
15.84%335.00M
11.65%336.30M
3.71%338.60M
1.63%355.30M
-16.08%289.20M
-14.07%301.20M
-10.13%326.50M
-24.93%349.60M
-23.76%344.60M
4.91%350.50M
16.11%363.30M
57.65%465.70M
71.99%452.00M
9.43%334.10M
-11.33%312.90M
-19.60%295.40M
-42.61%262.80M
-33.87%305.30M
-27.45%352.90M
Total equity
-27.84%269.00M
-21.70%303.90M
-52.14%337.40M
-47.51%368.00M
-49.05%372.80M
-47.59%388.10M
-7.25%704.90M
-10.48%701.10M
7.07%731.70M
0.72%740.50M
-9.00%760.00M
-11.58%783.20M
-25.44%683.40M
-22.40%735.20M
-12.09%835.20M
-8.47%885.80M
-5.36%916.60M
4.99%947.40M
8.56%950.10M
5.40%967.80M
Cash Flow Statement
Net operating income
-130.81%-6.50M
38.97%-8.30M
3.68%-15.70M
60.61%10.60M
2914.29%21.10M
-623.08%-13.60M
12.37%-16.30M
112.07%6.60M
103.17%700.00K
388.89%2.60M
43.98%-18.60M
-610.39%-54.70M
-1127.78%-22.10M
98.19%-900.00K
28.60%-33.20M
22.22%-7.70M
95.42%-1.80M
-1029.55%-49.70M
-164.76%-46.50M
-133.00%-9.90M
Net investment
66.13%-2.10M
53.62%-3.20M
21.69%-6.50M
-1.69%-6.00M
-182.67%-6.20M
-7.81%-6.90M
-16.90%-8.30M
50.83%-5.90M
400.00%7.50M
-154.24%-6.40M
-120.52%-7.10M
66.29%-12.00M
-121.93%-2.50M
198.33%11.80M
183.78%34.60M
-37.45%-35.60M
-96.08%11.40M
-1190.91%-12.00M
-603.66%-41.30M
-351.46%-25.90M
Net financing
-100.53%-300.00K
-15.38%2.20M
-122.06%-3.00M
-490.48%-8.20M
1912.90%56.20M
8.33%2.60M
254.55%13.60M
-98.28%2.10M
-24.00%-3.10M
-93.75%2.40M
-79.59%-8.80M
5904.76%121.90M
30.56%-2.50M
1436.00%38.40M
-2.08%-4.90M
-90.91%-2.10M
95.17%-3.60M
109.43%2.50M
90.10%-4.80M
-210.00%-1.10M

Revenue

By Business

Period:
No Data

By Region

Period:
No Data

FAQs

What is the total revenue of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its total revenue reached 824.50M, with a year-on-year change of 837.60M.

What are the current assets of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its current assets were 332.60M, with a year-on-year change of 11.61.

What are the total assets of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its total assets of Myriad Genetics Inc were 706.60M, with a year-on-year change of -31.24.

What are the total liabilities of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its total liabilities of Myriad Genetics Inc were 338.60M, with a year-on-year change of 3.71.

What is the total equity of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its total equity of Myriad Genetics Inc was 368.00M, with a year-on-year change of -47.51.

What is the net operating income of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its net operating income of Myriad Genetics Inc was -67.80M, with a year-on-year change of 22.95.

What is the net investment of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its net investment of Myriad Genetics Inc was -27.40M, with a year-on-year change of -130.25.

What is the net financing of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its net financing of Myriad Genetics Inc was 64.20M, with a year-on-year change of 967.57.

What is the Earnings Per Share (EPS) of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.95, with a year-on-year change of -181.22.

What is the net income of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its net income was -365.90M, with a year-on-year change of -187.43.

What is the net margin of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its net profit margin was -44.38, with a year-on-year change of -192.00.

What is the gross margin of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its gross margin was 69.93, with a year-on-year change of 0.06.

What is the debt-to-asset ratio of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its debt-to-asset ratio was 16.97, with a year-on-year change of 340.33.

What is the Return on Equity (ROE) of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its Return on Equity (ROE) was -68.45, with a year-on-year change of -299.06.

What is the Return on Assets (ROA) of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its Return on Assets (ROA) was -42.20, with a year-on-year change of -260.34.

What is the operating profit of Myriad Genetics Inc?

According to Myriad Genetics Inc's FY2025 earnings report, its operating profit was -67.80M, with a year-on-year change of 22.95.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy